| ¿µ¹® | sensory nerve | ÇÑ±Û | °¨°¢½Å°æ |
|---|---|---|---|
| ¼³¸í | °¨°¢¼¼Æ÷°¡ ¹ÞÀº ÀÚ±ØÀ» ÁßÃ߽Ű濡 Àü´ÞÇÏ´Â ½Å°æ. ´«À̳ª ÇǺΠµî¿¡ ÀÖ´Â °¨°¢±â°¡ ¿ÜºÎ·ÎºÎÅÍ ÀÚ±ØÀ» ¹ÞÀ¸¸é °¨°¢½Å°æÀ» °ÅÃÄ Ã´¼ö¿Í ´ë³ú°ÑÁú±îÁö °¨°¢ÀÌ Àü´ÞµÈ´Ù. ÀÌ¿Í °°ÀÌ ¿ÜºÎ·ÎºÎÅÍ ³»ºÎ¸¦ ÇâÇØ Àü´ÞµÇ´Â °¨°¢½Å°æÀº ±¸½É¼º ½Å°æ°èÅëÀ̸ç, ¿ø½É¼º ¿îµ¿½Å°æ°èÅë ¹× ÀÚÀ²½Å°æ°èÅë¿¡ ÇÊÀûÇÏ´Â ¸»ÃʽŰæÀÇ ÇϳªÀÌ´Ù. ÀÌ °¨°¢½Å°æ¿¡´Â Èİ¢½Å°æ(³ú½Å°æ¥°)-½Ã°¢½Å°æ(³ú½Å°æ¥±)-´«µ¹¸²½Å°æ(³ú½Å°æ¥²)-»ïÂ÷½Å°æ(³ú½Å°æ¥´)-¾ó±¼½Å°æ(³ú½Å°æ¥¶)-û°¢½Å°æ(³ú½Å°æ¥·)-ÇôÀενŰæ(³ú½Å°æ¥¸)-¹ÌÁֽŰæ(³ú½Å°æ¥¹) ¹× ô¼ö½Å°æÀÌ ÀÖ´Ù. °¨°¢½Å°æ Áß ¹ÌÁֽŰæÀ» Á¦¿ÜÇÏ¸é ¸ðµÎ µÎºÎ¿¡ ºÐÆ÷µÇ¾î ÀÖ°í, Èİ¢½Å°æ-½Ã°¢½Å°æ-û°¢½Å°æÀÇ ¼¼°¡Áö´Â ƯÈ÷ ºÐÈµÈ °¨°¢»óÇǸ¦ Áö¹èÇÑ´Ù. ÇôÀενŰæÀº ¹Ì°¢ÀÇ ¸»´ÜÀåÄ¡¿Í ±× ¹ÛÀÇ ºÎºÐ¿¡ ¿¬°áµÇ°í ¹ÌÁֽŰæÀº Èä°°ú º¹°ÀÇ ±â°ü¿¡ ºÐÆ÷µÇ¾î ±¸½É¼º Ãæ°ÝÀ» ÁßÃß¿¡ Àü´ÞÇÏ¸ç »ïÂ÷½Å°æÀº ô¼öÀÇ °¢ ¸¶µð¿¡ ÀÖ´Â ½Å°æ¿¡ ÇØ´çÇÏ¿©(¸Ó¸®ÀÇ ÇǺÎ-Á¡¸· µîÀÇ Ç¥¸é°¨°¢°ú ½ÉºÎ°¨°¢À» °üÀåÇÑ´Ù. ô¼öÀÇ °¨°¢½Å°æ°èÅë¿¡µµ ÇÇºÎ¿Í ½ÉºÎ, ³»ÀåÀÇ ºÐÆ÷¿¡ µû¸¥ ±¸º°ÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | cranial nerve | ÇÑ±Û | ³ú½Å°æ |
|---|---|---|---|
| ¼³¸í | ´ëºÎºÐÀÇ ½Å°æÀº ô¼ö¸¦ ÅëÇØ¼ ³ª°£´Ù. ±×·¯³ª ¸î¸îÀÇ ½Å°æÀº ³ú¿¡¼ ¹Ù·Î ³ª°£´Ù. ÀÌ·¸°Ô ³ú¿¡¼ ¹Ù·Î ³ª°¡´Â ½Å°æÀ» ³ú½Å°æÀ̶ó°í ÇÑ´Ù. ÀÌ ³ú½Å°æÀº 12°³·Î ¸ðµÎ ´ëĪÀûÀÎ ½ÖÀ¸·Î Á¸ÀçÇÑ´Ù. ÀÌ ³ú½Å°æÀº ÁַΠƯ¼ö°¨°¢(½Ã°¢, û°¢, Èİ¢, ¹Ì°¢)°ú ¾ó±¼ µîÀÇ ÀϺΠ±ÙÀ°À» Áö¹èÇÏ°í ½ÉÀåÀ̳ª ³»ÀåÀÇ Áö¹èµµ ÀϺΠ´ã´çÇϰí ÀÖ´Ù. 12°³ÀÇ ½Å°æÀº °¢°¢ ´ÙÀ½°ú °°Àº À̸§°ú °íÀ¯¹øÈ£¸¦ °¡Áö°í ÀÖ´Ù. -Èİ¢½Å°æ(olfactory nerve)£Èİ¢À» ´ã´çÇÏ´Â ½Å°æ, -½Ã°¢½Å°æ(optic nerve)£½Ã°¢À» ´ã´çÇÏ´Â ½Å°æ. -´«µ¹¸²½Å°æ(oculomotor nerve)£¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ, -µµ¸£·¡½Å°æ(trochlear nerve)£´«ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. -»ïÂ÷½Å°æ(trigeminal nerve)£3°³ÀÇ °¡Áö¸¦ °¡Áö´Â ½Å°æÀ¸·Î ¾ó±¼ÀÇ °¨°¢°ú ¾Ã±â¸¦ À§ÇÑ ±ÙÀ°À» ¿òÁ÷ÀÌ´Â ¿ªÇÒÀ» ÇÑ´Ù. -°¡µ¹¸²½Å°æ(abducent nerve)£´«ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. -¾ó±¼½Å°æ(facial nerve)£¾ó±¼ ±ÙÀ°ÀÇ ¿îµ¿À» ´ã´çÇÏ´Â ½Å°æ. Áï ¾ó±¼ÀÌ ¿©·¯ °¡Áö Ç¥Á¤À» ³»´Â °ÍÀº ÀÌ ½Å°æÀÇ ÀÛ¿ëÀÌ´Ù. ±×¸®°í ÇôÀÇ ¾ÕºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÏ´Â ¿ªÇÒµµ ÇÑ´Ù. -¾È¶ã´ÞÆØÀ̽Űæ(vestibulocochlear nerve)£¾È¶ã½Å°æ°ú ´ÞÆØÀ̽ŰæÀÇ 2°¡Áö ½Å°æÀ¸·Î ÀÌ·ç¾îÁø ½Å°æÀ¸·Î ¸ðµÎ ±Í¸¦ Áö¹èÇÏ´Â ½Å°æÀÌ´Ù. ¾È¶ã½Å°æÀº ÆòÇü°¨°¢À» ´ã´çÇÏ´Â °÷ÀÎ ±ÍÀÇ ¾È¶ã¿¡¼ ³ª¿À´Â ½Å°æÀ¸·Î ÆòÇü°¨°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ ÀüÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ´ÞÆØÀ̽ŰæÀº û°¢À» °¨ÁöÇÏ´Â ´ÞÆØÀ̲®ÁúÀÇ ¸ð¾çÀ» °¡Áø ´ÞÆØÀÌ¿¡¼ ±â¿øÇÏ´Â ½Å°æÀ¸·Î û°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ Àü´ÞÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. -ÇôÀενŰæ(glossopharyngeal nerve)£¸» ±×´ë·Î Çô¿Í Àεκο¡ ºÐÆ÷ÇÏ´Â ½Å°æÀ¸·Î ÀÎÈĺÎÀÇ ¿òÁ÷ÀÓ°ú ÇôÀÇ µÞºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÑ´Ù. -¹ÌÁֽŰæ(vagus nerve)£¸» ±×´ë·Î ¾ÆÁÖ ¿©·¯ °÷¿¡ ºÐÆ÷ÇÏ¿© ºÐÆ÷¿µ¿ªÀÌ ¸ðÈ£ÇÑ ½Å°æÀÌ´Ù(vagus¶õ ¸ðÈ£ÇÑ À̶õ ¶æÀ» °¡Áø´Ù). ´ëºÎºÐÀÇ ³»Àå¿¡ ºÐÆ÷ÇÏ°í ¶Ç ½ÉÀå¿¡ ºÐÆ÷ÇÏ¿© ½ÉÀåÀÇ ¹Úµ¿¼ö¸¦ Á¶Á¤ÇÏ´Â ¿ªÇÒµµ ÇÑ´Ù. -´õºÎ½Å°æ(accessory nerve)£µîÀÇ ±ÙÀ°°ú ¸ñÀÇ ±ÙÀ°ÀÇ ÀϺθ¦ Áö¹èÇÏ´Â ½Å°æ. -Çô¹Ø½Å°æ(hypoglossal nerve)£ÇôÀÇ ¿òÁ÷ÀÓÀ» °üÀåÇÏ´Â ½Å°æ. |
||
| ¿µ¹® | afferent nerve | ÇÑ±Û | µé½Å°æ |
|---|---|---|---|
| ¼³¸í | ¸öÀÇ Áß½ÉÀ¸·Î µé¾î¿À´Â ½Å°æ, Áï °¨°¢½Å°æÀ» ÁöĪÇÏ´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | peripheral nerve | ÇÑ±Û | ¸»ÃʽŰæ |
|---|---|---|---|
| ¼³¸í | ÁßÃ߽Űæ°è¸¦ Á¦¿ÜÇÑ ³ª¸ÓÁö ¸ðµç½Å°æÀ» ¸»ÇÔ. ÁßÃ߽Űæ°è´Â ³ú¿Í ô¼ö¸¦ ¸»Çϸç, ±×¿Ü ³ª¸ÓÁö ½Å°æµé·Î½á ½ÇÁ¦ÀûÀ¸·Î °¢ ±â°üÀ̳ª »çÁö ¸»´Ü¿¡ ½Å°æÀÌ ºÐÆ÷Çϸç, ÀÚ±ØÀ» Àü´ÞÇÏ´Â ÀÏÀ» ÇÏ´Â ½Å°æÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÃʽŰæÀ̶ó ÇÑ´Ù. ³ú¿¡¼ ¹Ù·Î ³ª¿Í ºÐÆ÷ÇÏ´Â ³ú½Å°æ°ú ô¼ö¿¡¼ ±â½ÃÇϴ ô¼ö½Å°æµµ ¸ðµÎ ¸»ÃʽŰ濡 ÇØ´çÇÑ´Ù. ¶ÇÇÑ ¸»ÃʽŰ濡´Â °¢Á¾ ÀÚÀ²½Å°æÀ» ´ã´çÇÏ´Â ±³°¨½Å°æ, ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ. |
||
| GRF | gastrin-releasing factor; genetically related macrophage factor; gonadotropin-releasing factor; grow... |
|---|---|
| GF | gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa... |
| SGF | sarcoma growth factor; skeletal growth factor |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| receptors, transforming growth factor beta | Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behaviour of cells. Two types of transforming growth factor receptors have been recognised. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see receptors, epidermal growth factor-urogastrone). (12 Dec 1998) |
|---|---|
| growth factor | <biochemistry> A complex family of polypeptide hormones or biological factors that are produced by the body to control growth, division and maturation of blood cells by the bone marrow. They regulate the division and proliferation of cells and influence the growth rate of some cancers. These factors occur naturally but some can be synthesised using molecular biology techniques and are used clinically to stimulate normal white cell production following chemotherapy or bone marrow transplantation. Examples include epidermal growth factor, platelet-derived growth factor, fibroblast growth factor. Insulin and somatomedin are also growth factors, the status of nerve growth factor is more uncertain. Perturbation of growth factor production or of the response to growth factor is important in neoplastic transformation. (29 Sep 1997) |
| growth hormone-releasing factor | <endocrinology> Peptide hormone related to the glucagon family, released from the pituitary, acts on the adenohypophysis to release growth hormone. Synonym: somatoliberin, growth hormone-releasing factor. (20 Sep 2002) |
| platelet-derived growth factor | <growth factor> The major mitogen in serum for growth in culture of cells of connective tissue origin. It consists of 2 different but homologous polypeptides A and B (~30,000 D) linked by disulphide bonds. Believed to play a role in wound healing. It is carried in the alpha-granules of platelets and is released when platelets adhere to traumatised tissues. Connective tissue cells near the traumatised region respond by initiating the process of replication. The B chain is almost identical in sequence to p28sis, the transforming protein of simian sarcoma virus, that can transform only those cells that express receptors for platelet derived growth factor, suggesting that transformation is caused by autocrine stimulation. The receptor is a tyrosine kinase. Acronym: PDGF (12 Dec 1998) |
| sarcoma growth factor | <growth factor> Polypeptide released by sarcoma cells that promotes the growth of cells by binding to a cell surface receptor, the sarcoma cell is therefore self sufficient and independent of normal growth control. See: growth factors. The name is no longer commonly used. (18 Nov 1997) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| hepatocyte growth factor | <growth factor> Polypeptide mitogen originally shown to cause cell division in hepatocytes. In the liver, the main sources of hepatocyte growth factor are nonparenchymal cells. It is now clear that hepatocyte growth factor is a mitogen for a number of cell types and it is found in many cells outside the liver, including platelets. Hepatocyte growth factor is synthesised as a single chain precursor that is proteolytically cleaved to give a heavy chain (70 kD) and a light chain (30 kD) linked by a single disulphide bond. It contains multiple copies of the kringle domain. However, both the single chain precursor and the two chain forms of hepatocyte growth factor are biologically active and hepatocyte growth factor is generally isolated as a mixture of the two forms. Hepatocyte growth factor also alters cell motility and is now known to be identical to scatter factor. Acronym: HGF (18 Nov 1997) |
| pro-transforming growth factor-alpha processing protease | <enzyme> Converts membrane-bound protgf-alpha to soluble tgf-alpha; mw 84 kD Registry number: EC 3.4.21.- Synonym: protgf-alpha converting enzyme, protgfalpha processing protease (26 Jun 1999) |
| schwannoma derived growth factor | <growth factor> A growth factor containing an EGF like domain, mitogenic for astrocytes, Schwann cells and fibroblasts. (18 Nov 1997) |
| insulin like growth factor | <growth factor> Insulin like growth factors I and II are polypeptides with considerable sequence similarity to insulin. They are capable of eliciting the same biological responses, including mitogenesis in cell culture. On the cell surface, there are two types of insulin like growth factor receptor, one of which closely resembles the insulin receptor (which is also present). Insulin like growth factor I = somatomedin A = somatomedin C Insulin like growth factor II = MSA (Multiplication stimulating activity). Insulin like growth factor 1 is released from the liver in response to growth hormone. Acronym: IGF (18 Nov 1997) |
| insulin-like growth-factor binding protein 1 | One of the six homologous proteins that specifically bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits igf binding to cell surface receptors and thereby inhibits igf-mediated mitogenic and cell metabolic actions. (proc soc exp biol med 1993;204(1):4-29) (12 Dec 1998) |
| insulin-like growth factor-binding protein 2 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth factor binding protein 3 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin like growth-factor-binding protein 4 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth-factor-binding-protein 5 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|